Ubiquitin specific peptidase 22 is a protein that in humans is encoded by the USP22 gene on chromosome 17.[5]
USP22 is known to function as a histone deubiquitinating component of the transcription regulatory histone acetylation (HAT) complex SAGA.[6]
Zhang Y, Yao L, Zhang X, Ji H, Wang L, Sun S, Pang D (August 2011). "Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer". Journal of Cancer Research and Clinical Oncology. 137 (8): 1245–53. doi:10.1007/s00432-011-0998-9. PMID21691749. S2CID9026376.
Ling SB, Sun DG, Tang B, Guo C, Zhang Y, Liang R, Wang LM (December 2012). "Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest". Cellular and Molecular Biology. 58 Suppl: OL1803-8. PMID23217440.
Xu H, Liu YL, Yang YM, Dong XS (January 2012). "Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth". International Journal of Colorectal Disease. 27 (1): 21–30. doi:10.1007/s00384-011-1275-8. PMID21773699. S2CID25987858.
Liu YL, Yang YM, Xu H, Dong XS (March 2011). "Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer". Journal of Surgical Oncology. 103 (3): 283–9. doi:10.1002/jso.21802. PMID21337558. S2CID30706374.